We are live on ! Find out more
CNTX icon

Context Therapeutics
CNTX

39 hedge funds and large institutions have $45M invested in Context Therapeutics in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% more capital invested

Capital invested by funds: $43.7M → $45M (+$1.25M)

0% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 9

3.11% less ownership

Funds ownership: 79.61% → 76.5% (-3.1%)

7% less funds holding

Funds holding: 42 → 39 (-3)

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

Holders
39
Holders Change
-3
Holders Change %
-7.14%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
9
Reduced
9
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LM
Luminus Management
Texas
+$236K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$77K
3
MCCA
Mill Creek Capital Advisors
Pennsylvania
+$75.2K
4
GS
GTS Securities
New York
+$31.8K
5
BOCH
Blue Owl Capital Holdings
New York
+$28.8K

Top Sellers

Rank Fund Capital Flow
1
ABG
Ally Bridge Group
New York
-$708K
2
AI
Allostery Investments
Connecticut
-$582K
3
WP
Woodline Partners
California
-$490K
4
SC
Shay Capital
New York
-$116K
5
AAA
Affinity Asset Advisors
New York
-$103K
Name Holding Trade Value Shares
Change 		Change in
Stake
VCIM
26
Velan Capital Investment Management
Georgia
$65.5K +$7.19K +10,000 +11%
CHAM
27
Clear Harbor Asset Management
Connecticut
$37.9K – – –
GS
28
GTS Securities
New York
$28.9K +$31.8K +44,176 New
Cerity Partners
29
Cerity Partners
New York
$13.1K +$7.19K +10,000 +100%
CC
30
Caxton Corporation
New Jersey
$12.1K – – –
Millennium Management
31
Millennium Management
New York
$11.2K -$22.7K -31,604 -65%
CWM
32
Congress Wealth Management
Massachusetts
$9.83K – – –
Osaic Holdings
33
Osaic Holdings
Arizona
$6.83K +$360 +500 +5%
TRCT
34
Tower Research Capital (TRC)
New York
$4.86K -$4.24K -5,890 -44%
Morgan Stanley
35
Morgan Stanley
New York
$2.29K +$2.44K +3,400 +3,400%
NFSG
36
Newbridge Financial Services Group
Florida
$1.31K +$1.44K +2,000 New
Bank of America
37
Bank of America
North Carolina
$356 +$71 +99 +22%
UBS Group
38
UBS Group
Switzerland
$242 -$45 -62 -14%
SS
39
SBI Securities
Japan
$74 – – –
ABG
40
Ally Bridge Group
New York
– -$708K -1,157,448 Closed
AI
41
Allostery Investments
Connecticut
– -$582K -950,166 Closed
SC
42
Shay Capital
New York
– -$116K -189,853 Closed
UOC
43
UBS O'Connor
Illinois
– -$41.4K -67,631 Closed
LCM
44
Landscape Capital Management
New Jersey
– -$25.2K -41,216 Closed
XT
45
XTX Topco
Cayman Islands
– -$9.59K -15,673 Closed
JP Morgan Chase
46
JP Morgan Chase
New York
– -$49 -80 Closed
1
2

CNTX Hedge Fund Activity: Q2 2025 in Review

39 of the 7,603 institutional investors tracked by Wall St. Rank reported a position in Context Therapeutics (CNTX) for Q2 2025, worth a combined $45M — up 2.9% from $43.7M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of CNTX and 4 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 9 added.

The largest buyer was Luminus Management, opening a new position worth an estimated $236K. The largest seller was Ally Bridge Group, exiting entirely with an estimated $708K sold.

  • 39 institutional investors held Context Therapeutics (CNTX) as of Q2 2025, down from 42 in Q1 2025.
  • Funds reported $45M of Context Therapeutics stock for Q2 2025, up 2.9% quarter-over-quarter.
  • 4 funds opened new Context Therapeutics positions in Q2 2025 and 7 closed out, a net change of -3 holders.
  • The largest Context Therapeutics buyer in Q2 2025 was Luminus Management, an estimated $236K added.
  • The largest Context Therapeutics seller in Q2 2025 was Ally Bridge Group, an estimated $708K sold.

Based on aggregated 13F filings for Q2 2025.